The annual CPhI Worldwide event, which this year is being held in Barcelona on 4–6 October, has evolved from a small active ingredients show into a ‘meet and greet’ for the whole pharmaceutical supply chain.
This year, for the first time, the exhibition will have a new Finished Dosage Formulation (FDF) event alongside the other halls. According to organiser UBM, it will target various segments of the formulation supply chain, including pharmaceutical manufacturers, contract manufacturing, outlicensing and dossier specialists, end product distributors and generic pharma companies.
It will act as ‘a global meeting point for any company looking to grow, launch or distribute finished formulations domestically or internationally,’ said the organiser.
Cara Turner, Event Manager UBM EMEA, explained the strategy behind the move: ‘Many existing CPhI visitors and exhibitors have diversified their offering into finished dosage forms in the past 5 years and what we are now attempting to bring is a new audience to the CPhI family, effectively bridging the gap between CPhI and ICSE (the existing show for outsourcing and contract manufacturing) and the end user.’
The introduction of the FDF event is a reflection of the unprecedented pace at which developments in finished dosage forms have moved forward in recent years, she added. Since the introduction of the FDF zone at CPhI WW in 2011, it has grown to become the third largest segment of the overall show, totalling 11,000m2 in floor space in 2015. The move also reflects the growth of in- and outlicensing currently being embraced by the industry as Big Pharma looks to cut investment costs and share risks.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.